Defibrillators Market Will Grow Rapidly In Coming Years

Defibrillators Industry

The global defibrillators market size was estimated at USD 7.32 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030.

Increasing product development activities, rising incidence of sudden cardiac arrest, growing awareness among the general public, and supportive initiatives by governments & healthcare organizations are some of the key factors fueling industry growth. In May 2021, Rapid Response Revival Research Ltd.-an Australian company-received a CE mark for its CellAED, the world’s first personal automated external defibrillator (AED) for home use. This supported the company’s growth strategy.

The COVID-19 pandemic adversely impacted the industry, particularly the International Classification of Diseases (ICDs) market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.

Increasing geriatric population globally and technological advancements are other key factors that are projected to significantly impact market growth. The older population, particularly those aged between 65 years and above, is more vulnerable to chronic diseases, such as cardiovascular diseases (CVDs), which often require the placement of defibrillators to restore a normal heart rhythm by delivering an electric shock to the heart. For instance, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans" reported that around 54.1 million (16.3%) individuals in the U.S. are aged 65 years or above. Thus, the growing geriatric population contributes to the increasing product demand.

Gather more insights about the market drivers, restrains and growth of the Global Defibrillators market

Defibrillators Market Segments Highlights:

North America held the largest revenue share in 2023 due to the advanced healthcare infrastructure, supportive policies driving adoption of public access AEDs, and deeper penetration of the technologically advanced devices
Asia Pacific is anticipated to register the highest CAGR of 9.3% over the forecast period owing to the high prevalence of cardiovascular diseases in China and India and increasing healthcare expenditure
The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge in the market
Some of the leading players in the market are headquartered in Asia such as Asahi Kasei, Nihon Kohden, and Microport, thus contributing to the regional market growth
Europe held a significant revenue share in 2023 owing to initiatives by key companies and well-established healthcare infrastructure
For instance, in January 2020, Medtronic received the CE mark for its Cobalt and Crome lineup of defibrillators. This extended the company’s cardiac solutions offerings and enabled it to commercialize the products across Europe

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global smart orthopedic implants market size was valued at USD 25.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2030.
The global implantable cardioverter defibrillators market size was estimated at USD 3.81 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030.

Segments Covered in the Report

Grand View Research has segmented the global defibrillators market on the basis of product, end-use, and region:

Defibrillators Product Outlook (Revenue, USD Million, 2018 - 2030)

Implantable Cardioverter Defibrillators (ICD)
- S-ICD
- T-ICD
External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable Cardioverter Defibrillators

Defibrillators End-use Outlook (Revenue, USD Million, 2018 - 2030)